• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

    10/8/21 5:01:18 PM ET
    $BHG
    Medical Specialities
    Health Care
    Get the next $BHG alert in real time by email
    SC 13D/A 1 d198450dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Bright Health Group, Inc.

    (Name of Issuer)

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

    10920V 107

    (CUSIP Number)

    Jennifer Y. Ishiguro

    StepStone Group LP

    4225 Executive Square, Suite 1600

    La Jolla, CA 90237

    (858) 558-9700

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    September 20, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      StepStone Group LP

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      44,650,937

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      44,650,937

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      44,650,937

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      7.1%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Global Partners VII-A, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      5,358,000

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      5,358,000

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,358,000

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.9%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Global Partners VII-C, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      516,912

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      516,912

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      516,912

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.1%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Opportunities IV, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      21,059,052

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      21,059,052

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      21,059,052

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      3.3%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Master G, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      2,290,572

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      2,290,572

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,290,572

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.4%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN

     


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring SPV VII, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      2,212,572

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      2,212,572

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,212,572

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.4%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN

     


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      AU Special Investments, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      8,246,418

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      8,246,418

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      8,246,418

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      1.3%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Opportunities VI, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      3,305,300

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      3,305,300

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      3,305,300

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.5%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Opportunities VI-D, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      188,884

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      188,884

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      188,884

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      < 0.1%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring SPV VII-E, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      418,221

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      418,221

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      418,221

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.1%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Opportunities V, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      969,477

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      969,477

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      969,477

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.2%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 10920V 107

     

      1.    

      Names of Reporting Persons.

     

      Greenspring Opportunities V-D, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      0

         8.   

      Shared Voting Power

     

      85,529

         9.   

      Sole Dispositive Power

     

      0

       10.   

      Shared Dispositive Power

     

      85,529

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      85,529

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      <0.1%

    14.  

      Type of Reporting Person (See Instructions)

     

      PN


    Explanatory Note

    On September 20, 2021, StepStone Group Inc., a Delaware corporation, and StepStone Group LP, a Delaware limited partnership, completed the acquisition of Greenspring Associates, LLC and certain of its affiliates or subsidiaries (the “Acquisition”). As a result of the Acquisition, StepStone Group LP became the investment manager of certain funds that hold shares of the Issuer (as defined below). This Amendment No. 1 to Schedule 13D is the initial filing on Schedule 13D of StepStone Group LP, Greenspring Opportunities V, L.P., and Greenspring Opportunities V-D, L.P. with respect to the Issuer, and is Amendment No. 1 with respect to the other Reporting Persons (as defined below). As a result of the Acquisition, Greenspring Associates, LLC, Charles Ashton Newhall, and James Lim no longer have beneficial ownership with respect to the securities of the Issuer, and they are not included as Reporting Persons on this Amendment No. 1.

     

    Item 1.

    Security and Issuer

    Item 1 of the Schedule 13D is amended and restated as follows:

    This Schedule 13D relates to the shares of common stock, $0.0001 par value per share (“Common Stock”), of Bright Health Group, Inc., a Delaware corporation (the “Issuer”), which has its principal executive offices at 8000 Norman Center Drive, Suite 1200, Minneapolis, MN 55437.

     

    Item 2.

    Identity and Background

    Item 2 of the Schedule 13D is amended and restated as follows:

     

      (a)

    This Schedule 13D is being filed by Greenspring Global Partners VII-A, L.P., Greenspring Global Partners VII-C, L.P., AU Special Investments, L.P., Greenspring Opportunities IV, L.P, Greenspring Opportunities VI, L.P., Greenspring Opportunities VI-D, L.P., Greenspring Master G, L.P., Greenspring SPV VII, L.P., Greenspring SPV VII-E, L.P., Greenspring Opportunities V, L.P. and Greenspring Opportunities V-D, L.P. (collectively, the “Greenspring Funds”), and StepStone Group LP (“StepStone”). StepStone is the investment manager of the Greenspring Funds. StepStone Group Holdings LLC (“StepStone Group Holdings”) is the general partner of StepStone, and StepStone Group Inc. is the sole managing member of StepStone Group Holdings. The agreement among the Reporting Persons to file this Schedule 13D jointly in accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, is attached hereto as Exhibit 1.

     

      (b)

    The address of the principal business office of StepStone is 4225 Executive Square, Suite 1600, La Jolla, CA 90237. The address of the principal business office of each of the other Reporting Persons is 100 Painters Mill Road, Suite 700, Owings Mills, MD 21117.

     

      (c)

    The principal business of StepStone is to be a global private markets investment firm focused on providing customized investment solutions and advisory and data services to its clients. The principal business of the Greenspring Funds is to invest in securities.

     

      (d)

    During the last five years none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     

      (e)

    During the last five years none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree of final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

      (f)

    Each of the Reporting Persons is a Delaware limited partnership.


    Item 3.

    Source and Amount of Funds or Other Consideration

    Item 3 of the Schedule 13D is amended as follows:

    StepStone acquired beneficial ownership of the shares of the Common Stock in connection with the Acquisition. The source of the funds for acquiring these shares was the working capital of the Greenspring Funds.

     

    Item 4.

    Purpose of Transaction

    Item 4 of the Schedule 13D is amended and restated as follows:

    The Reporting Persons acquired the shares of Common Stock reported on this Schedule 13D and hold their shares of Common Stock for investment purposes. Adair Newhall, a Partner at StepStone, serves as a member of the board of directors of the Issuer.

    Each Reporting Person expects to continuously review such person’s investment in the Issuer and, depending on various factors including but not limited to, the price of the shares of Common Stock, the terms and conditions of the transaction, prevailing market conditions and such other considerations as such Reporting Person deems relevant, may at any time or from time to time, and subject to any required regulatory approvals, acquire additional shares of Common Stock, preferred stock or other securities convertible into or exercisable or exchangeable for Common Stock from time to time on the open market, in privately- negotiated transactions, directly from the Issuer, or upon the exercise or conversion of securities convertible into or exercisable or exchangeable for Common Stock.

    Each Reporting Person also may, at any time, subject to compliance with applicable securities laws and regulatory requirements dispose or distribute some or all of its of his Common Stock or such other securities as it or he owns or may subsequently acquire depending on various factors, including but not limited to, the price of the shares, the terms and conditions of the transaction and prevailing market conditions, as well as the liquidity and diversification objectives.

    Consistent with their investment intent, each Reporting Person may from time to time discuss with the Issuer’s management, directors, other shareholders and others, the Issuer’s performance, business, strategic direction, capital structure, product development program, prospects and management, as well as various ways of maximizing stockholder value, which may or may not include extraordinary transactions.

    Except as indicated herein, no Reporting Person, as a stockholder of the Issuer, has any plans or proposals that relates or would result in any of the transactions or other matters specified in clauses (a) though (j) of Item 4 of Schedule 13D. Each Reporting Person may, at any time and from time to time, review or reconsider its or his position and/or change its or his purpose and/or formulate plans or proposals with respect thereto.

    The information set forth in Item 6 below is incorporated by reference to this Item 4.

     

    Item 5.

    Interest in Securities of the Issuer

    Item 5 of the Schedule 13D is amended and restated as follows:

     

      (a)

    The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on 630,222,819 outstanding shares of Common Stock as reported by the Issuer in its Form 10-Q filed with the Securities and Exchange Commission on August 11, 2021.

     

      (b)

    The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.

     

      (c)

    The transactions by the Reporting Persons effected within the past sixty days are set forth in Schedule A hereto which is incorporated by reference herein into this Item 5(c).

     

      (d)

    No person other than the Reporting Persons disclosed in this Schedule 13D is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock subject to this Schedule 13D.

     

      (e)

    As a result of the Acquisition, Greenspring Associates, LLC, Mr. Lim, and Mr. Newhall no longer have beneficial ownership with respect to the reported securities.


    Item 6.

    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

    Item 6 of the Schedule 13D is amended and restated as follows:

    Registration Rights Agreement

    The Greenspring Funds and certain of the Issuer’s other investors have entered into a Registration Rights Agreement with the Issuer (the “Registration Rights Agreement”). The stockholders party to the Registration Rights Agreement are entitled to certain customary registration rights with respect to the shares of Common Stock, including “demand” registration rights and “piggyback” registration rights.

    The foregoing summary of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the Registration Rights Agreement which is filed as an exhibit hereto and incorporated by reference herein.

    Lock-up Agreement and Market Stand-Off

    In connection with the Issuer’s initial public offering, the Greenspring Funds entered into a lock-up agreement for a period of 180 days with the representatives of the several underwriters (the “Lock-up Agreement”). Pursuant to the Lock-up Agreement, the Greenspring Funds, subject to certain exceptions, agreed not to sell or otherwise transfer any shares of Common Stock or securities convertible into, exchangeable for or exercisable for Common Stock, without the prior consent of the representatives. The Greenspring Funds are also party to market stand-off provisions with the Issuer which imposes restrictions on the sale of shares of Common Stock for a period of 180 days.

     

    Item 7.

    Material to be Filed as Exhibits

    Item 7 of the Schedule 13D is amended and restated as follows:

    Exhibit 1    Joint Filing Agreement

    Exhibit 2    Second Amended and Restated Registration Rights Agreement, dated as of November 15, 2018 (incorporated by reference to Exhibit 10.2 of the Issuer’s Registration Statement on Form S-1 (File No. 333-256286))

    Exhibit 3    Amendment to Second Amended and Restated Registration Rights Agreement, dated as of May 19, 2021 (incorporated by reference to Exhibit 10.3 of the Issuer’s Registration Statement on Form S-1 (File No. 333-256286))


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: October 8, 2021

     

    STEPSTONE GROUP LP
    By:   StepStone Group Holdings, LLC,
    its general partner
    By:  

    /s/ Jennifer Y. Ishiguro

      Name:   Jennifer Y. Ishiguro
      Title:   Chief Legal Officer & Secretary
    GREENSPRING GLOBAL PARTNERS VII-A, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name:   Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING GLOBAL PARTNERS VII-C, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name:   Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    AU SPECIAL INVESTMENTS, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name:   Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING OPPORTUNITIES IV, L.P.
    By:   StepStone Group LP, its investment manager


    By: StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING OPPORTUNITIES VI, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING OPPORTUNITIES VI-D, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING MASTER G, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING SPV VII, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary


    GREENSPRING SPV VII-E, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING OPPORTUNITIES V, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary
    GREENSPRING OPPORTUNITIES V-D, L.P.
    By:   StepStone Group LP, its investment manager
    By:   StepStone Group Holdings, LLC,
    its general partner
      By:  

    /s/ Jennifer Y. Ishiguro

        Name: Jennifer Y. Ishiguro
        Title:   Chief Legal Officer & Secretary


    Schedule A

     

    Record Holder

       Date of
    Transaction
       Number
    of Shares
    Acquired /
    (Disposed)
       Transaction    Price
    Per
    Share
    Greenspring Opportunities V, L.P.    8/16/2021    230,651    Purchase    $9.50
    Greenspring Opportunities V-D, L.P.    8/16/2021    20,349    Purchase    $9.50
    Greenspring Opportunities V, L.P.    8/17/2021    13,751    Purchase    $9.48
    Greenspring Opportunities V-D, L.P.    8/17/2021    1,213    Purchase    $9.48
    Greenspring Opportunities V, L.P.    8/18/2021    172,611    Purchase    $9.39
    Greenspring Opportunities V-D, L.P.    8/18/2021    15,228    Purchase    $9.39
    Greenspring Opportunities V, L.P.    8/19/2021    233,280    Purchase    $9.30
    Greenspring Opportunities V-D, L.P.    8/19/2021    20,580    Purchase    $9.30
    Greenspring Opportunities V, L.P.    8/20/2021    319,184    Purchase    $9.77
    Greenspring Opportunities V-D, L.P.    8/20/2021    28,159    Purchase    $9.77
    Get the next $BHG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BHG

    DatePrice TargetRatingAnalyst
    10/11/2022Neutral → Underweight
    JP Morgan
    3/29/2022Overweight → Neutral
    JP Morgan
    3/4/2022$9.00 → $3.00Outperform → Sector Perform
    RBC Capital
    3/3/2022$4.00 → $2.00Underweight
    Morgan Stanley
    3/3/2022$5.00 → $3.50Neutral
    Goldman Sachs
    3/3/2022$5.50 → $4.00Overweight
    Barclays
    3/3/2022$10.00 → $5.00Overweight
    Piper Sandler
    3/2/2022Buy → Underperform
    BofA Securities
    More analyst ratings

    $BHG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Bright Health Group Adopts NeueHealth as Corporate Brand Name

      The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock

      1/17/24 4:05:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare

      Completes final repayment on secured credit facility eliminating the Company's secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare, Inc. ("Molina"). The sale closed, effective as of Januar

      1/2/24 4:30:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

      Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company's secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider enablement business Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final

      12/29/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    SEC Filings

    See more
    • Bright Health Group Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/24/24 5:09:44 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Inc. filed SEC Form 8-K: Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/4/24 9:17:32 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/2/24 4:32:58 PM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Financials

    Live finance-specific insights

    See more
    • Bright Health Group Reports Third Quarter 2023 Results

      Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r

      11/7/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group to Host Third Quarter 2023 Earnings Conference Call on November 7, 2023

      Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe

      10/13/23 8:00:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Reports Second Quarter 2023 Results

      Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi

      8/9/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Bright Health Group Inc. (Amendment)

      SC 13G/A - NeueHealth, Inc. (0001671284) (Subject)

      2/14/24 5:04:52 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

      SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

      2/14/24 9:37:57 AM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

      SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

      12/22/23 4:34:44 PM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Leadership Updates

    Live Leadership Updates

    See more
    • Bright Health Group Appoints Jay Matushak as Chief Financial Officer

      Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company's next Chief Financial Officer, effective May 12, 2023. Mr. Matushak will succeed Cathy Smith, who is stepping down to pursue another opportunity. Mr. Matushak, a seasoned finance and operational executive with deep expertise in the healthcare business, joined Bright Health in 2021. He currently serves as Senior Vice President of Finance and is responsible

      5/3/23 5:00:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Announces Retirement of General Counsel Keith Nelsen

      Jeff Craig, lead counsel for the Company's NeueHealth business, named General Counsel and Corporate Secretary Bright Health Group, Inc. ("Bright Health" or "The Company") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that Keith Nelsen will retire as General Counsel and Corporate Secretary. Jeff Craig, lead counsel for the Company's NeueHealth business, will be promoted to the role of General Counsel and Corporate Secretary effective March 18, 2022. Nelsen will stay on as a senior advisor with the Company until June 30, 2022, to ensure a smooth transition. "Keith has been a key leader for many of our mi

      3/15/22 4:35:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Names Leading Healthcare Expert to Board

      Matthew Manders to Join as Independent Director Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that leading healthcare expert Matt Manders will join the company's Board as an independent director, effective March 1. Manders brings a wealth of diverse healthcare experience, focus on operational excellence, and expertise in consumer-driven healthcare. Most recently, he served as president of Cigna Corporation's Government and Solutions organization, part of a 30-plus-year career with the company. In this role, Manders led and managed Cigna's U.S. Government busi

      3/1/22 8:10:00 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Yang Rick

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:05:33 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Walker Paul Edward

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:04:41 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Sandell Scott D

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:02:52 PM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bright Health Group downgraded by JP Morgan

      JP Morgan downgraded Bright Health Group from Neutral to Underweight

      10/11/22 12:28:36 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group downgraded by JP Morgan

      JP Morgan downgraded Bright Health Group from Overweight to Neutral

      3/29/22 7:08:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Gr downgraded by RBC Capital with a new price target

      RBC Capital downgraded Bright Health Gr from Outperform to Sector Perform and set a new price target of $3.00 from $9.00 previously

      3/4/22 6:06:15 AM ET
      $BHG
      Medical Specialities
      Health Care